SEKAX
Price
$22.30
Change
-$0.11 (-0.49%)
Updated
Nov 19 closing price
Net Assets
64.12M
VEIEX
Price
$34.03
Change
-$0.05 (-0.15%)
Updated
Nov 19 closing price
Net Assets
141.19B
Interact to see
Advertisement

SEKAX vs VEIEX

Header iconSEKAX vs VEIEX Comparison
Open Charts SEKAX vs VEIEXBanner chart's image
DWS Emerging Markets Equity A
Price$22.30
Change-$0.11 (-0.49%)
VolumeN/A
Net Assets64.12M
Vanguard Emerging Mkts Stock Idx I
Price$34.03
Change-$0.05 (-0.15%)
VolumeN/A
Net Assets141.19B
SEKAX vs VEIEX Comparison Chart in %
View a ticker or compare two or three
VS
SEKAX vs. VEIEX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SEKAX is a Hold and VEIEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 141B vs. SEKAX (64.1M). VEIEX pays higher dividends than SEKAX: VEIEX (2.61) vs SEKAX (0.00). SEKAX was incepted earlier than VEIEX: SEKAX (24 years) vs VEIEX (32 years). SEKAX (1.69) is less costly to investors than VEIEX (0.29). SEKAX is a more actively managed with annual turnover of: 61.00 vs. VEIEX (8.00). VEIEX has a lower initial minimum investment than SEKAX: VEIEX (0) vs SEKAX (1000). SEKAX annual gain was more profitable for investors over the last year : 22.13 vs. VEIEX (20.18). VEIEX return over 5 years is better than : 23.38 vs. SEKAX (4.18).
SEKAXVEIEXSEKAX / VEIEX
Total Expense Ratio1.170.29403%
Annual Report Gross Expense Ratio1.690.29583%
Fund Existence24 years32 years-
Gain YTD23.81222.205107%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets64.1M141B0%
Annual Yield % from dividends0.002.61-
Returns for 1 year22.1320.18110%
Returns for 3 years43.9447.2393%
Returns for 5 years4.1823.3818%
Returns for 10 years70.5878.6190%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUE0.58N/A
+0.02%
Cue Biopharma
RNGR13.51N/A
N/A
Ranger Energy Services
MTSR70.50N/A
N/A
Metsera Inc
CHPGU10.26N/A
N/A
Championsgate Acquisition Corp
TRVI11.05-0.26
-2.30%
Trevi Therapeutics